論文

2019年1月15日

Retinoic Acid Receptor Alpha Represses a Th9 Transcriptional and Epigenomic Program to Reduce Allergic Pathology

Immunity
  • Schwartz D
  • Farley T
  • Richoz N
  • Yao C
  • Shih H
  • Petermann F
  • Zhang Y
  • Sun H
  • Hayes E
  • Mikami Y
  • Jiang K
  • Davis F
  • Kanno Y
  • Milner J
  • Siegel R
  • Laurence A
  • Meylan F
  • O'Shea J
  • 全て表示

50
1
開始ページ
106
終了ページ
120.e10
DOI
10.1016/j.immuni.2018.12.014
出版者・発行元
Immunity

© 2018 CD4+ T helper (Th) differentiation is regulated by diverse inputs, including the vitamin A metabolite retinoic acid (RA). RA acts through its receptor RARα to repress transcription of inflammatory cytokines, but is also essential for Th-mediated immunity, indicating complex effects of RA on Th specification and the outcome of the immune response. We examined the impact of RA on the genome-wide transcriptional response during Th differentiation to multiple subsets. RA effects were subset-selective and were most significant in Th9 cells. RA globally antagonized Th9-promoting transcription factors and inhibited Th9 differentiation. RA directly targeted the extended Il9 locus and broadly modified the Th9 epigenome through RARα. RA-RARα activity limited murine Th9-associated pulmonary inflammation, and human allergic inflammation was associated with reduced expression of RA target genes. Thus, repression of the Th9 program is a major function of RA-RARα signaling in Th differentiation, arguing for a role for RA in interleukin 9 (IL-9) related diseases.

リンク情報
DOI
https://doi.org/10.1016/j.immuni.2018.12.014
URL
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85059451906&origin=inward
ID情報
  • DOI : 10.1016/j.immuni.2018.12.014
  • ISSN : 1074-7613

エクスポート
BibTeX RIS